Expert insights. Personalized for you.
Pharmaceutical supply chains have become global and complex. Insights on Life Sciences Pharmaceuticals Supply chain managementWith more outsourcing, new modalities, and novel ways to reach patients, it’s critical to ensure that they can withstand shocks. MORE
Insights on Life Sciences PharmaceuticalsThe COVID-19 pandemic has prompted pharma companies to rethink their organizational strategies. A survey of executives suggests where value might lie. MORE
Insights on Pharmaceuticals & Medical Products PharmaceuticalsCell and gene therapies are at the forefront of innovation and transforming how we treat and potentially cure certain diseases. What will the next decade hold for these life-changing therapies? MORE
Pharmaceutical and medtech companies can dramatically improve quality assurance processes by applying a ‘smart quality’ lens and cutting-edge technologies. Insights on Pharmaceuticals & Medical Products MORE
And although the pharmaceutical and healthcare industries know this is the way forward, they face some significant hurdles Precision medicine combines business opportunities with clinical health benefits. MORE
The CFO of the pharmaceutical company talks about what it took to develop a COVID-19 vaccine. Strategy & Corporate Finance Insights Pharmaceuticals Strategy & Corporate Finance Strategy MORE
Insights on Life Sciences Pharmaceuticals Supply chain managementClinical trials have increased in number and have become more complex, decentralized, and patient-centric. While this puts pressure on clinical drug supply, it also brings new opportunities. MORE
Insights on Pharmaceuticals & Medical ProductsAdvances in biological science could transform economies and societies, helping to tackle global challenges from climate change to pandemics. MORE
Insights on Pharmaceuticals & Medical ProductsIncreasingly, small biopharmaceutical companies are launching their new drugs themselves rather than relying on large pharma companies to do it for them. How can they get it right the first time? MORE
Pharmaceutical companies should reflect on their strategic stance to this promising new technology now. Insights on Pharmaceuticals & Medical Products PharmaceuticalsQuantum computing’s ability to simulate larger, more complex molecules could be game changing. MORE
The CEO of Eli Lilly offers perspectives on accelerating change in the industry. Our Insights MORE
Sponsor content from Indegene. Innovation Customer service Technology Sponsor Content MORE
Insights on Pharmaceuticals & Medical Products Pharmaceuticals Japan DigitalSanten CIO Minori Hara explains how IT is enabling the ophthalmological company to deliver a holistic sense of well-being around eye health. MORE
Insights on Pharmaceuticals & Medical Products Medical productsMedtech companies could play a major role in the digital transformation of healthcare that is under way, but they will have to make some big changes to the way they operate—and fast. MORE
Insights on Pharmaceuticals & Medical ProductsUnderstanding structural shifts in the market can help pharma stakeholders innovate and, ultimately, deliver benefits for patients. MORE
Our GOLD standard will help transform your pharmaceutical brand and achieve accelerated growth. Asia-Pacific MORE
Insights on Pharmaceuticals & Medical ProductsBuilding a successful digital health business involves several strategic steps, as illustrated through the lens of six digital health start-ups. MORE
Insights on Pharmaceuticals & Medical Products Pharmaceuticals Oncology/Cancer Analytics Big dataAdvanced analytics will transform cancer care, but companies have been slow to adopt it. Progress requires a strategy that not only builds data and talent but also embraces experimentation. MORE
Anne Nijs explains how the rare-disease group at Roche Pharmaceuticals pioneered a new model that puts the patient experience at the center of healthcare innovation and delivery. Insights on Pharmaceuticals & Medical Products Pharmaceuticals Product development MORE
Insights on Pharmaceuticals & Medical Products Pharmaceuticals BiotechnologyViral-vector gene therapies show great promise, but the full extent of their clinical impact in the long term is not yet certain. Success depends on innovative solutions that remain under development. MORE
Insights on Life Sciences Medical products PharmaceuticalsBiopharma companies should consider a new, integrated approach to evidence-generation strategies to better demonstrate the value of therapies to all stakeholders. MORE
That rule of life is no secret to pharmaceutical companies across the globe. Japan remains the world’s second-biggest pharmaceuticals market, behind only the United States and China. The biggest change for pharma in Japan was the 2014 revision of the nation’s keystone pharmaceuticals law, renamed the PMD Act—for pharmaceutical and medical devices. Older people need more medicine. MORE
Insights on Pharmaceuticals & Medical Products Health care services Medical products Health care providers MORE
Pharmaceutical and medical-device companies can get the most value from “smart quality” processes enabled with new technologies by adopting a holistic approach to building culture and capabilities. Insights on Life Sciences Pharmaceuticals Leadership Strategy MORE
Insights on Pharmaceuticals & Medical Products Medical productsSleep deprivation has become a global problem. Can the burgeoning sleep-tech industry provide solutions? MORE
Insights on Life Sciences PharmaceuticalsBy rethinking the approach to regulatory submissions, pharma companies can reduce timelines and increase their chances of successful product approvals. MORE
There are lessons for other industries in the way pharma companies use mergers to innovate, work more efficiently, and bolster product portfolios. Strategy & Corporate Finance Insights MORE
Insights on Pharmaceuticals & Medical ProductsA review of the funding, operational, technological, and regulatory factors that allowed for fast development of COVID-19 vaccines shows which will remain relevant for future efforts—and which won’t. MORE
Insights on Life Sciences Pharmaceuticals Medical products ChinaChinese biopharma is making a mark on the global stage as the rapidly evolving regulatory landscape and maturing innovation ecosystem spur significant value creation. MORE
Insights on Pharmaceuticals & Medical Products Pharmaceuticals Public health Health care services Managing in Uncertainty InnovationModerna’s delivery of a COVID-19 vaccine comes on the heels of revolutionary science that may accelerate innovation across the industry well into the future. MORE
Insights on Pharmaceuticals & Medical ProductsLeaders should consider the lessons and achievements of the COVID-19 crisis in forging new innovation aspirations—and the mechanisms needed to execute them. MORE
Pharmaceutical companies are increasingly turning to the concept of agility to help them transform their R&D functions. Insights on Pharmaceuticals & Medical Products MORE
Insights on Pharmaceuticals & Medical Products PharmaceuticalsThe smart quality approach allows pharma companies to digitize, automate, and integrate their quality controls, making them faster, more effective, and more efficient. MORE
Insights on Pharmaceuticals & Medical Products PharmaceuticalsThe COVID-19 pandemic has catalyzed the adoption of decentralized clinical trials while highlighting the critical benefits of virtual trials and improving the patient and physician experience. MORE
Insights on Pharmaceuticals & Medical Products Pharmaceuticals Medical products Public & Social Sector AfricaFor decades, private companies, investors, and public-health leaders have taken a pass on domestic vaccine manufacturing. MORE
Insights on Pharmaceuticals & Medical Products Biotechnology Pharmaceuticals Oncology/CancerThe small number of people with rare diseases raises challenges for the development and launch of all therapies for such conditions, but rare cancers face extra barriers to widespread treatment. MORE
Insights on Pharmaceuticals & Medical Products Public health Pharmaceuticals Health care services Healthcare Pharmaceuticals & Medical Products Public and Social SectorsEmployers can consider a set of actions that supports COVID-19-vaccine adoption among employees by building conviction and making vaccination as convenient and “costless” as possible. MORE
Insights on Life Sciences Pharmaceuticals Medical products United KingdomThe United Kingdom is Europe’s leading biotech hub in breakthrough life-sciences start-ups. How is this hub maturing relative to its global peers, and what lies ahead on the road to sustainable scale? MORE
Insights on Pharmaceuticals & Medical Products Biotechnology PharmaceuticalsWith rising US adoption, biosimilars are gathering even more momentum. Successful companies will innovate their commercial models, rethink their portfolio management, and accelerate their R&D. MORE
Cedric Francois, the CEO of pharmaceutical company Apellis, discusses possible approaches to treating COVID-19 patients. Insights on Pharmaceuticals & Medical Products MORE
Insights on Pharmaceuticals & Medical ProductsTwo experts discuss how quantum computing can help solve intractable problems in drug discovery and development. MORE
Pharmaceuticals Related Topics 
McKinsey & Company
MARCH 2, 2021
Insights on Pharmaceuticals & Medical Products Pharmaceuticals Japan DigitalSanten CIO Minori Hara explains how IT is enabling the ophthalmological company to deliver a holistic sense of well-being around eye health.
McKinsey & Company
FEBRUARY 12, 2021
Insights on Pharmaceuticals & Medical ProductsIncreasingly, small biopharmaceutical companies are launching their new drugs themselves rather than relying on large pharma companies to do it for them. How can they get it right the first time?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
McKinsey
MAY 27, 2020
Cedric Francois, the CEO of pharmaceutical company Apellis, discusses possible approaches to treating COVID-19 patients. Insights on Pharmaceuticals & Medical Products
McKinsey
SEPTEMBER 17, 2020
Our GOLD standard will help transform your pharmaceutical brand and achieve accelerated growth. Asia-Pacific
McKinsey
OCTOBER 11, 2018
There are lessons for other industries in the way pharma companies use mergers to innovate, work more efficiently, and bolster product portfolios. Strategy & Corporate Finance Insights
McKinsey
SEPTEMBER 1, 2018
Insights on Pharmaceuticals & Medical ProductsUnderstanding structural shifts in the market can help pharma stakeholders innovate and, ultimately, deliver benefits for patients.
McKinsey
OCTOBER 27, 2017
The CEO of Eli Lilly offers perspectives on accelerating change in the industry. Our Insights
McKinsey & Company
JUNE 18, 2021
Pharmaceutical companies should reflect on their strategic stance to this promising new technology now. Insights on Pharmaceuticals & Medical Products PharmaceuticalsQuantum computing’s ability to simulate larger, more complex molecules could be game changing.
McKinsey & Company
DECEMBER 10, 2021
The CFO of the pharmaceutical company talks about what it took to develop a COVID-19 vaccine. Strategy & Corporate Finance Insights Pharmaceuticals Strategy & Corporate Finance Strategy
McKinsey & Company
DECEMBER 21, 2021
Insights on Life Sciences PharmaceuticalsThe COVID-19 pandemic has prompted pharma companies to rethink their organizational strategies. A survey of executives suggests where value might lie.
McKinsey & Company
JULY 28, 2021
Insights on Pharmaceuticals & Medical Products PharmaceuticalsCell and gene therapies are at the forefront of innovation and transforming how we treat and potentially cure certain diseases. What will the next decade hold for these life-changing therapies?
|
McKinsey & Company
APRIL 9, 2021
Insights on Pharmaceuticals & Medical Products Public health Pharmaceuticals Health care services Healthcare Pharmaceuticals & Medical Products Public and Social SectorsEmployers can consider a set of actions that supports COVID-19-vaccine adoption among employees by building conviction and making vaccination as convenient and “costless” as possible.
McKinsey & Company
APRIL 14, 2021
Insights on Pharmaceuticals & Medical Products Pharmaceuticals Medical products Public & Social Sector AfricaFor decades, private companies, investors, and public-health leaders have taken a pass on domestic vaccine manufacturing.
McKinsey & Company
JULY 15, 2021
Anne Nijs explains how the rare-disease group at Roche Pharmaceuticals pioneered a new model that puts the patient experience at the center of healthcare innovation and delivery. Insights on Pharmaceuticals & Medical Products Pharmaceuticals Product development
McKinsey & Company
JANUARY 10, 2022
Pharmaceutical and medical-device companies can get the most value from “smart quality” processes enabled with new technologies by adopting a holistic approach to building culture and capabilities. Insights on Life Sciences Pharmaceuticals Leadership Strategy
McKinsey & Company
JUNE 7, 2021
Insights on Pharmaceuticals & Medical Products Biotechnology PharmaceuticalsWith rising US adoption, biosimilars are gathering even more momentum. Successful companies will innovate their commercial models, rethink their portfolio management, and accelerate their R&D.
McKinsey & Company
AUGUST 27, 2021
Insights on Pharmaceuticals & Medical Products Pharmaceuticals Public health Health care services Managing in Uncertainty InnovationModerna’s delivery of a COVID-19 vaccine comes on the heels of revolutionary science that may accelerate innovation across the industry well into the future.
McKinsey & Company
MAY 17, 2021
Insights on Pharmaceuticals & Medical Products Pharmaceuticals BiotechnologyViral-vector gene therapies show great promise, but the full extent of their clinical impact in the long term is not yet certain. Success depends on innovative solutions that remain under development.
McKinsey & Company
APRIL 23, 2021
Insights on Pharmaceuticals & Medical Products Pharmaceuticals Oncology/Cancer Analytics Big dataAdvanced analytics will transform cancer care, but companies have been slow to adopt it. Progress requires a strategy that not only builds data and talent but also embraces experimentation.
Harvard Business
SEPTEMBER 28, 2020
Sponsor content from Indegene. Innovation Customer service Technology Sponsor Content
McKinsey & Company
APRIL 14, 2021
Insights on Pharmaceuticals & Medical Products PharmaceuticalsThe smart quality approach allows pharma companies to digitize, automate, and integrate their quality controls, making them faster, more effective, and more efficient.
McKinsey & Company
SEPTEMBER 23, 2021
Pharmaceutical supply chains have become global and complex. Insights on Life Sciences Pharmaceuticals Supply chain managementWith more outsourcing, new modalities, and novel ways to reach patients, it’s critical to ensure that they can withstand shocks.
Harvard Business
MARCH 11, 2018
That rule of life is no secret to pharmaceutical companies across the globe. Japan remains the world’s second-biggest pharmaceuticals market, behind only the United States and China. The biggest change for pharma in Japan was the 2014 revision of the nation’s keystone pharmaceuticals law, renamed the PMD Act—for pharmaceutical and medical devices. Older people need more medicine.
McKinsey & Company
JUNE 10, 2021
Insights on Pharmaceuticals & Medical Products PharmaceuticalsThe COVID-19 pandemic has catalyzed the adoption of decentralized clinical trials while highlighting the critical benefits of virtual trials and improving the patient and physician experience.
McKinsey & Company
JUNE 23, 2021
Insights on Pharmaceuticals & Medical Products Medical productsSleep deprivation has become a global problem. Can the burgeoning sleep-tech industry provide solutions?
McKinsey & Company
JANUARY 13, 2021
Insights on Pharmaceuticals & Medical ProductsBuilding a successful digital health business involves several strategic steps, as illustrated through the lens of six digital health start-ups.
McKinsey & Company
NOVEMBER 29, 2021
Insights on Life Sciences Pharmaceuticals Supply chain managementClinical trials have increased in number and have become more complex, decentralized, and patient-centric. While this puts pressure on clinical drug supply, it also brings new opportunities.
McKinsey & Company
MAY 13, 2021
Insights on Pharmaceuticals & Medical Products Biotechnology Pharmaceuticals Oncology/CancerThe small number of people with rare diseases raises challenges for the development and launch of all therapies for such conditions, but rare cancers face extra barriers to widespread treatment.
McKinsey & Company
SEPTEMBER 16, 2021
Insights on Life Sciences PharmaceuticalsBy rethinking the approach to regulatory submissions, pharma companies can reduce timelines and increase their chances of successful product approvals.
McKinsey
NOVEMBER 12, 2020
Insights on Pharmaceuticals & Medical ProductsLeaders should consider the lessons and achievements of the COVID-19 crisis in forging new innovation aspirations—and the mechanisms needed to execute them.
McKinsey & Company
MAY 7, 2021
Insights on Pharmaceuticals & Medical Products Medical productsMedtech companies could play a major role in the digital transformation of healthcare that is under way, but they will have to make some big changes to the way they operate—and fast.
McKinsey
OCTOBER 23, 2020
Insights on Pharmaceuticals & Medical ProductsTwo experts discuss how quantum computing can help solve intractable problems in drug discovery and development.
McKinsey & Company
JANUARY 29, 2021
Pharmaceutical and medtech companies can dramatically improve quality assurance processes by applying a ‘smart quality’ lens and cutting-edge technologies. Insights on Pharmaceuticals & Medical Products
McKinsey & Company
OCTOBER 29, 2021
Insights on Life Sciences Pharmaceuticals Medical products ChinaChinese biopharma is making a mark on the global stage as the rapidly evolving regulatory landscape and maturing innovation ecosystem spur significant value creation.
McKinsey & Company
MAY 19, 2021
Insights on Pharmaceuticals & Medical Products Health care services Medical products Health care providers
McKinsey & Company
DECEMBER 2, 2021
Insights on Life Sciences Medical products PharmaceuticalsBiopharma companies should consider a new, integrated approach to evidence-generation strategies to better demonstrate the value of therapies to all stakeholders.
McKinsey
MAY 14, 2020
Insights on Pharmaceuticals & Medical ProductsAdvances in biological science could transform economies and societies, helping to tackle global challenges from climate change to pandemics.
McKinsey & Company
MAY 13, 2021
Insights on Pharmaceuticals & Medical ProductsA review of the funding, operational, technological, and regulatory factors that allowed for fast development of COVID-19 vaccines shows which will remain relevant for future efforts—and which won’t.
McKinsey & Company
DECEMBER 3, 2021
Insights on Life Sciences Pharmaceuticals Medical products United KingdomThe United Kingdom is Europe’s leading biotech hub in breakthrough life-sciences start-ups. How is this hub maturing relative to its global peers, and what lies ahead on the road to sustainable scale?
McKinsey
JULY 23, 2019
Pharmaceutical companies are increasingly turning to the concept of agility to help them transform their R&D functions. Insights on Pharmaceuticals & Medical Products
83 
Let's personalize your content